Shares of Edwards Lifesciences Corp. EW slid 2.05% to $70.33 Friday, on what proved to be an all-around favorable trading ...

Shares of Edwards Lifesciences Corp. EW slipped 1.44% to $71.80 Thursday, on what proved to be an all-around dismal trading ...

Full Year 2024 Results Key Financial Results Revenue: US$5.44b (up 8.6% from FY ...

Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion ...

IRVINE, Calif., February 25, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton, Dickinson and Co. (BD) has appointed longtime Edwards Lifesciences sales and marketing exec Tim Patz as the new ...

Embodied carbon reduction strategies helped guide the design of Edwards Lifesciences’ Mussallem Innovation Center, a mix of ...

Company Performance Edwards Lifesciences demonstrated robust performance in Q4 2024, with total sales growing by 9% year-over-year to $1.39 billion. The company's focus on structural heart disease ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...